Backed by Y Combinator, and with offices in Paris and Cambridge, MA, we specialize in the clinical research of Non-Invasive Brain Stimulation technologies for the treatment of CNS disorders.
We are pioneers in Non-Invasive Brain Stimulation technologies with a particular focus on transcranial neuromodulation devices using high frequency magnetic pulses that target multiple well known, but neglected pathogenic mechanisms in neurodegenerative disorders.
Actipulse Neuroscience is focused on leading world class research with a particular emphasis on respecting the highest clinical and ethical standards.
Major Depressive Disorder
Actipulse Neuroscience has for goal to be the golden standard of neuromodulation technologies in the next five years and to become an integral part of the treatment of the millions of patients suffering from neurological and psychiatric disorders and dementia in the world.
We want to tell you about us and how this revolutionary technology will impact the world with your help.